학술논문
LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1298-S1299
Subject
Language
ISSN
0923-7534